← All companies

BHST

BioHarvest Sciences Inc. Common Stock

BHST Nasdaq Pharmaceutical Preparations EDGAR ↗

$1.47

+0.02 +1.38%

Key statistics

from XBRL data in SEC filings

Market cap ⓘ

$33.3M

Revenue (TTM) ⓘ

$34.5M

Net income (TTM) ⓘ

-$11.1M

EPS (TTM) ⓘ

$-0.60

P/E ratio ⓘ

—

Dividend yield ⓘ

—

Free cash flow ⓘ

-$9.58M

Cash ⓘ

$23.0M

Total assets ⓘ

—

Gross margin ⓘ

—

52-week range ⓘ

$1.42 – $12.80

Recent SEC filings

40 most recent

Annual, quarterly & current reports

6-K REPORT Sep 15, 2026

6-K REPORT Sep 15, 2026

6-K REPORT Sep 14, 2026

6-K REPORT Sep 3, 2026

6-K REPORT Aug 12, 2026

6-K REPORT Aug 11, 2026

6-K REPORT Jul 29, 2026

6-K REPORT Jul 28, 2026

6-K REPORT Jul 16, 2026

6-K REPORT Jul 15, 2026

6-K REPORT Jun 18, 2026

6-K REPORT May 28, 2026

6-K REPORT May 14, 2026

6-K REPORT May 14, 2026

6-K REPORT May 14, 2026

6-K REPORT May 13, 2026

6-K REPORT May 12, 2026

6-K REPORT May 11, 2026

6-K REPORT May 1, 2026

6-K REPORT Apr 29, 2026

40-F BIOHARVEST SCIENCES INC. - FORM 40-F SEC FILING Mar 31, 2026

6-K REPORT Mar 27, 2026

6-K REPORT Mar 17, 2026

6-K REPORT Mar 16, 2026

6-K REPORT Mar 6, 2026

6-K REPORT Mar 5, 2026

6-K REPORT Mar 3, 2026

6-K REPORT Jan 7, 2026

6-K REPORT Dec 18, 2025

6-K REPORT Dec 3, 2025

6-K REPORT Nov 13, 2025

6-K REPORT Nov 12, 2025

6-K CURRENT REPORT Nov 10, 2025

6-K REPORT Nov 10, 2025

6-K REPORT Nov 4, 2025

6-K REPORT Oct 31, 2025

6-K REPORT Oct 31, 2025

6-K REPORT Sep 23, 2025

6-K REPORT Sep 22, 2025

6-K REPORT Sep 10, 2025